In hepatocellular carcinoma (HCC), the competitive binding of high-mobility group box 1 (HMGB1) and RICTOR in the mTOR pathway to miR-200 family members, such as miR-429, supports tumor self-renewal, tumorigenesis, and glutamine metabolism. This evidence concerns the gene MTOR and hepatocellular carcinoma.